OptiNose (NASDAQ: OPTN) reported Q1 EPS of ($0.12), $0.02 worse than the analyst estimate of ($0.10). Revenue for the quarter came in at $14.9 million versus the consensus estimate of $12.94 million.

GUIDANCE:

OptiNose sees FY2024 revenue of $85-95 million, versus the consensus of $90.46 million.

For earnings history and earnings-related data on OptiNose (OPTN) click here.